IYH ETF Analysis: U.S. Healthcare | NYSE
Healthcare Equity | NYSE, USA | Market Cap: 4.730m USD | 12M Return: 29.3% | US4642877629 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 69.9M
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The iShares U.S. Healthcare ETF (IYH) is a passively managed exchange-traded fund that seeks to track the performance of the U.S. equity healthcare sector by investing at least 80% of its assets in the component securities of its underlying index. The fund is structured as a non-diversified vehicle, meaning it may concentrate a larger portion of its holdings in a smaller number of issuers compared to diversified funds.
Launched in 2000 and listed on the NYSE, IYH provides exposure to a sector that typically encompasses pharmaceuticals, biotechnology, medical devices, healthcare providers, and managed care companies. As a sector-focused ETF, it offers investors targeted access to healthcare-related equities rather than broad market exposure.
- GLP-1 obesity drug sales surge lifts pharma valuations
- Medicare drug price negotiation expands under IRA policy
- Aging US demographics sustain healthcare utilization growth
As of November 11, 2026, the stock is trading at USD 79.13 with a total of 437,310 shares traded. Over the past week, the price has changed by +2.37%, over one month by +9.07%, over three months by +11.53% and over the past year by +29.25%.
Current recommended Stop Loss: 77.30 (which is 2.3% or 1.2 ATR below the current price).
U.S. Healthcare has no consensus analysts rating.